EFFECT OF AGGRESSIVE HEMOPERFUSION ON THE CLINICAL COURSE OF PATIENTS WITH PARAQUAT POISONING

被引:31
作者
SUZUKI, K [1 ]
TAKASU, N [1 ]
OKABE, T [1 ]
ISHIMATSU, S [1 ]
UEDA, A [1 ]
TANAKA, S [1 ]
FUKUDA, A [1 ]
ARITA, S [1 ]
KOHAMA, A [1 ]
机构
[1] KAWASAKI MED SCH, DEPT MATH, KURASHIKI, OKAYAMA 70101, JAPAN
关键词
D O I
10.1177/096032719301200411
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The effect of aggressive haemoperfusion; i.e. haemoperfusion of 10 h or more during the first 24 h after ingestion, on the clinical course of paraquat poisoning was studied. Among 40 patients admitted within 15 h after ingestion of paraquat with an SIPP of less than 100 (h x mug ml-1), 21 received aggressive haemoperfusion and 19 received conventional haemoperfusion; i.e. haemoperfusion of less than 10 h during the same period. Survival rates of patients with severity between an SIPP of 100 and Proudfoot's curve in the two groups were compared by the log-rank test. Aggressive haemoperfusion did not improve the outcome but did improve the survival rates; that is, the number of patients surviving at particulalr points in time (p<0.05), The length of haemoperfusion for the aggressive haemoperfusion group was longer than that for the conventional group on the first day (P<0.001), but the difference was insignificant during the following two days. Neither the time from ingestion to haemoperfusion, urine volume from the first to third day, nor initial plasma-paraquat concentrations and SIPP were significant between groups, These findings imply that aggressive haemoperfusion reduces the severity of paraquat poisoning and elongates survival time. We, therefore, propose that the efficacy of more aggressive haemoperfusion, such as the 'continuous haemoperfusion' proposed by Okonek et al., should be further studied.
引用
收藏
页码:323 / 327
页数:5
相关论文
共 21 条
[1]   PARAQUAT POISONING - THE RATIONALE FOR CURRENT TREATMENT REGIMES [J].
DAVIES, DS .
HUMAN TOXICOLOGY, 1987, 6 (01) :37-40
[2]   HEMOPERFUSION - A USEFUL THERAPY FOR A SEVERELY POISONED PATIENT [J].
DEBROE, ME ;
BISMUTH, C ;
DEGROOT, G ;
HEATH, A ;
OKONEK, S ;
RITZ, DR ;
VERPOOTEN, GA ;
VOLANS, GN ;
WIDDOP, B .
HUMAN TOXICOLOGY, 1986, 5 (01) :11-14
[3]  
HAMPSON ECGM, 1990, J PHARMACOL EXP THER, V254, P732
[4]   FAILURE OF HEMOPERFUSION AND HEMODIALYSIS TO PREVENT DEATH IN PARAQUAT POISONING - A RETROSPECTIVE REVIEW OF 42 PATIENTS [J].
HAMPSON, ECGM ;
POND, SM .
MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1988, 3 (01) :64-71
[5]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[6]   REMOVAL OF PARAQUAT FROM BLOOD BY HEMOPERFUSION OVER SORBENT MATERIALS [J].
MAINI, R ;
WINCHESTER, JF .
BRITISH MEDICAL JOURNAL, 1975, 3 (5978) :281-282
[7]  
MASCIETAYLOR BH, 1983, LANCET, V1, P1376
[8]   ENZYME LINKED IMMUNOSORBENT-ASSAY (ELISA) FOR PARAQUAT [J].
NIEWOLA, Z ;
WALSH, ST ;
DAVIES, GE .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1983, 5 (03) :211-218
[9]   EFFICACY OF GUT LAVAGE, HEMODIALYSIS, AND HEMOPERFUSION IN THERAPY OF PARAQUAT OR DIQUAT INTOXICATION [J].
OKONEK, S ;
HOFMANN, A ;
HENNINGSEN, B .
ARCHIVES OF TOXICOLOGY, 1976, 36 (01) :43-51
[10]  
OKONEK S, 1980, LANCET, V2, P589